Nabil Ismaili

1.0k total citations
65 papers, 724 citations indexed

About

Nabil Ismaili is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nabil Ismaili has authored 65 papers receiving a total of 724 indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Oncology, 19 papers in Surgery and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nabil Ismaili's work include Breast Cancer Treatment Studies (9 papers), Global Cancer Incidence and Screening (8 papers) and HER2/EGFR in Cancer Research (7 papers). Nabil Ismaili is often cited by papers focused on Breast Cancer Treatment Studies (9 papers), Global Cancer Incidence and Screening (8 papers) and HER2/EGFR in Cancer Research (7 papers). Nabil Ismaili collaborates with scholars based in Morocco, France and Lebanon. Nabil Ismaili's co-authors include Hassan Errihani, Aude Fléchon, Saïd Afqir, Pierre-Étienne Heudel, Noureddine Benjaafar, Sanaa Elmajjaoui, Hind M’rabti, Samia Arifi, Yassir Sbitti and Habiba Kadiri and has published in prestigious journals such as Journal of Hematology & Oncology, Radiotherapy and Oncology and Orphanet Journal of Rare Diseases.

In The Last Decade

Nabil Ismaili

59 papers receiving 700 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nabil Ismaili Morocco 17 404 218 161 125 86 65 724
Nestory Masalu Tanzania 17 400 1.0× 127 0.6× 214 1.3× 72 0.6× 101 1.2× 55 770
Serkan Keskın Türkiye 15 423 1.0× 146 0.7× 79 0.5× 241 1.9× 141 1.6× 62 708
Li‐Min Sun Taiwan 18 256 0.6× 279 1.3× 149 0.9× 181 1.4× 113 1.3× 45 856
İbrahim Vedat Bayoğlu Türkiye 17 606 1.5× 147 0.7× 100 0.6× 268 2.1× 147 1.7× 75 843
Mustafa Oktay Tarhan Türkiye 18 612 1.5× 108 0.5× 105 0.7× 228 1.8× 180 2.1× 63 867
L. Quéro France 15 256 0.6× 239 1.1× 70 0.4× 329 2.6× 95 1.1× 100 758
Seema Gulia India 14 310 0.8× 242 1.1× 241 1.5× 148 1.2× 87 1.0× 51 813
Isabella Corazziari Italy 12 512 1.3× 156 0.7× 187 1.2× 282 2.3× 90 1.0× 16 1.0k
Nagashree Seetharamu United States 14 494 1.2× 155 0.7× 95 0.6× 261 2.1× 62 0.7× 99 984
Chonlakiet Khorprasert Thailand 10 363 0.9× 206 0.9× 115 0.7× 263 2.1× 59 0.7× 31 718

Countries citing papers authored by Nabil Ismaili

Since Specialization
Citations

This map shows the geographic impact of Nabil Ismaili's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nabil Ismaili with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nabil Ismaili more than expected).

Fields of papers citing papers by Nabil Ismaili

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nabil Ismaili. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nabil Ismaili. The network helps show where Nabil Ismaili may publish in the future.

Co-authorship network of co-authors of Nabil Ismaili

This figure shows the co-authorship network connecting the top 25 collaborators of Nabil Ismaili. A scholar is included among the top collaborators of Nabil Ismaili based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nabil Ismaili. Nabil Ismaili is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ghazi, Bouchra, et al.. (2025). Cervical cancer in Morocco: a literature review on risk factors, prevalence, and healthcare challenges. Pan African Medical Journal. 50. 11–11.
2.
Elmajjaoui, Sanaa, Nabil Ismaili, & Noureddine Benjaafar. (2020). COVID-19, Brachytherapy, and Gynecologic Cancers: a Moroccan Experience. SN Comprehensive Clinical Medicine. 2(8). 1035–1038. 5 indexed citations
3.
Ismaili, Nabil, et al.. (2020). Management of breast cancer during COVID‐19 pandemic in Morocco. The Breast Journal. 26(8). 1618–1619. 9 indexed citations
4.
Bouzidi, Abderrahmane Al, et al.. (2020). Primary intrapulmonary malignant peripheral nerve sheath tumor: A rare case. Cancer Treatment and Research Communications. 25. 100243–100243. 2 indexed citations
5.
Ismaili, Nabil, et al.. (2020). Advances in the management of non-small cell lung cancer (NSCLC): A new practice changing data from asco 2020 annual meeting. Cancer Treatment and Research Communications. 25. 100239–100239. 19 indexed citations
6.
Ismaili, Nabil. (2020). COVID-19 and gynecological cancers: A Moroccan point-of-view. Radiotherapy and Oncology. 148. 227–228. 8 indexed citations
7.
Cheikh, Amine, et al.. (2016). Evaluation of the cost of cervical cancer at the National Institute of Oncology, Rabat. Pan African Medical Journal. 23. 209–209. 20 indexed citations
8.
Ismaili, Nabil, et al.. (2015). The burden among family caregivers of elderly cancer patients: prospective study in a Moroccan population. BMC Research Notes. 8(1). 347–347. 35 indexed citations
9.
Arifi, Samia, et al.. (2015). Treatment of Adult Soft Tissue Sarcomas: An Overview. PubMed. 3(1-2). 69–87. 20 indexed citations
10.
Ismaili, Nabil, et al.. (2014). Demographic, clinical, pathological, molecular, treatment characteristics and outcomes of nonmetastatic inflammatory breast cancer in Morocco: 2007 and 2008. Experimental Hematology and Oncology. 3(1). 1–1. 12 indexed citations
11.
Boutayeb, Saber, et al.. (2014). Neoadjuvant chemotherapy in well-differentiated fetal adenocarcinoma: a case report. BMC Research Notes. 7(1). 283–283. 6 indexed citations
12.
Ismaili, Nabil, Saïd Afqir, Rhizlane Belbaraka, et al.. (2012). Cancers urologiques : congrès de l’ECCO/ESMO 2011. La Presse Médicale. 41(12). 1181–1187. 1 indexed citations
13.
Ismaili, Nabil. (2011). A rare bladder cancer - small cell carcinoma: review and update. Orphanet Journal of Rare Diseases. 6(1). 75–75. 45 indexed citations
14.
Ismaili, Nabil, et al.. (2011). Chemotherapy in advanced bladder cancer: current status and future. Journal of Hematology & Oncology. 4(1). 35–35. 64 indexed citations
15.
Ismaili, Nabil, et al.. (2011). Bevacizumab 5 or 7.5 mg/kg in Metastatic Colorectal Cancer Can Be Infused Safely Over 10 Minutes. Journal of Gastrointestinal Cancer. 43(2). 244–248. 4 indexed citations
16.
Sbitti, Yassir, et al.. (2011). Breast cancer treatment and sexual dysfunction: Moroccan women's perception. BMC Women s Health. 11(1). 29–29. 57 indexed citations
17.
Ismaili, Nabil, et al.. (2010). An unusual presentation of non-Hodgkin lymphoma. 2(1). 15–18. 1 indexed citations
18.
Lalya, Issam, Nabil Ismaili, Rachid Razıne, et al.. (2010). Breast cancer in moroccan young women: a retrospective study. BMC Research Notes. 3(1). 286–286. 17 indexed citations
19.
Heudel, Pierre-Étienne, Fadi El Karak, Nabil Ismaili, Jean‐Pierre Droz, & Aude Fléchon. (2009). Micropapillary bladder cancer: a review of Léon Bérard Cancer Center experience. BMC Urology. 9(1). 5–5. 27 indexed citations
20.
Afqir, Saïd, Nabil Ismaili, Samir Ahid, et al.. (2009). Nasopharyngeal carcinoma in adolescents: a retrospective review of 42 patients. European Archives of Oto-Rhino-Laryngology. 266(11). 1767–1773. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026